Will Tesla Stock Go Up In 2026?
EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…
Buy
63
DHT.U.TO Quote, Financials, Valuation and Earnings
Last price:
$12.24
Seasonality move
:
-1.03%
Day range:
$12.24 - $12.24
52-week range:
$7.65 - $12.25
Dividend yield:
3.15%
P/E ratio:
520.50x
P/S ratio:
4.22x
P/B ratio:
1.30x
Volume:
--
Avg. volume:
121
1-year change:
43.16%
Market cap:
$674.4M
Revenue:
$138.5M
EPS (TTM):
-$0.03
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, DRI Healthcare Trust has -- downside to fair value with a price target of -- per share.
DHT.U.TO vs. S&P 500
-
Over the past 5 trading days, DRI Healthcare Trust has overperformed the S&P 500 by 4.03% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
DRI Healthcare Trust does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
DRI Healthcare Trust revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter DRI Healthcare Trust reported revenues of $29.8M.
Earnings Growth
-
DRI Healthcare Trust has grown year-over-year earnings for 3 quarters straight. In the most recent quarter DRI Healthcare Trust reported earnings per share of --.
Enterprise value:
1B
EV / Invested capital:
--
Price / LTM sales:
4.22x
EV / EBIT:
69.85x
EV / Revenue:
6.02x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
449.15x
Price / Operating cash flow:
298.95x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$10.3M
Return On Assets:
0.16%
Net Income Margin (TTM):
1.02%
Return On Equity:
0.27%
Return On Invested Capital:
0.18%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $113.1M | $201.1M | -- | $41.6M | -- | |
| Gross Profit | -$9.2M | $80.2M | $10.3M | $13.9M | -- | |
| Operating Income | -$19.8M | $57.9M | -- | $7.6M | -- | |
| EBITDA | $62M | $159.5M | -- | $33.7M | -- | |
| Diluted EPS | $1.75 | $0.21 | -$0.03 | -$0.03 | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $145.6M | $111.2M | $91.2M | $112.1M | $100.7M | |
| Total Assets | $454.9M | $453.8M | $692.3M | $903.4M | $962M | |
| Current Liabilities | $4.4M | $4M | $6.4M | $14.1M | $18.1M | |
| Total Liabilities | $74.3M | $74.3M | $323.9M | $351.7M | $441.9M | |
| Total Equity | $380.6M | $379.4M | $368.4M | $551.7M | $520.1M | |
| Total Debt | $69.9M | $69.4M | $315.6M | $331.3M | $419M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $77.1M | $92.4M | $141.3M | $48.2M | $43.2M | |
| Cash From Investing | -$325.5M | -$142.6M | -$135.1M | -$116.4M | -$5M | |
| Cash From Financing | $227.7M | $106M | $39.5M | $72M | -$19M | |
| Free Cash Flow | -$243.6M | -$308.7M | $2.3M | -$66.8M | $33.2M | |
DHT.U.TO
Sector
Market Cap
$674.4M
$29M
Price % of 52-Week High
99.92%
52.89%
Dividend Yield
3.15%
0%
Shareholder Yield
-2.25%
-1.4%
1-Year Price Total Return
43.16%
-19%
Beta (5-Year)
--
0.518
Dividend yield:
3.15%
Annualized payout:
$0.36
Payout ratio:
1345.08%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$11.91
200-day SMA
Buy
Level
$9.76
Bollinger Bands (100)
Buy
Level
10.24 - 11.32
Chaikin Money Flow
Sell
Level
-226.7K
20-day SMA
Buy
Level
$11.65
Relative Strength Index (RSI14)
Buy
Level
98.02
ADX Line
Buy
Level
81.3
Williams %R
Sell
Level
-1.4493
50-day SMA
Buy
Level
$11.07
MACD (12, 26)
Buy
Level
0.31
25-day Aroon Oscillator
Buy
Level
92
On Balance Volume
Sell
Level
-481.2K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.9265)
Buy
CA Score
(Annual)
Level (0.2032)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-14.7448)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
DRI Healthcare Trust is an unincorporated open-ended company. It engages in the provision of differentiated exposure to the fast-growing pharmaceutical and biotechnology industries through ownership and acquisition of royalties on pharmaceutical products with a focus on delivering attractive growth in cash receipts from royalty assets over the long term. The company was founded on October 21, 2020 and is headquartered in Toronto, Canada.
Stock Forecast FAQ
In the current month, DHT.U.TO has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DHT.U.TO average analyst price target in the past 3 months is --.
-
Where Will DRI Healthcare Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that DRI Healthcare Trust share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About DRI Healthcare Trust?
Analysts are divided on their view about DRI Healthcare Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that DRI Healthcare Trust is a Sell and believe this share price will rise from its current level to --.
-
What Is DRI Healthcare Trust's Price Target?
The price target for DRI Healthcare Trust over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DHT.U.TO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for DRI Healthcare Trust is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of DHT.U.TO?
You can purchase shares of DRI Healthcare Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase DRI Healthcare Trust shares.
-
What Is The DRI Healthcare Trust Share Price Today?
DRI Healthcare Trust was last trading at $12.24 per share. This represents the most recent stock quote for DRI Healthcare Trust. Yesterday, DRI Healthcare Trust closed at $12.24 per share.
-
How To Buy DRI Healthcare Trust Stock Online?
In order to purchase DRI Healthcare Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get DHT.U.TO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DHT.U.TO
Sector
P/E ratio
520.50x
24.19x
PEG ratio
0.00x
-0.01x
P/B ratio
1.30x
1.84x
Price / LTM sales
4.22x
1.61x
Growth Metrics
DHT.U.TO
Sector
Revenue growth
1.84%
4.6%
Earnings growth
100%
10.88%
Revenue (5-year growth)
--
6.5%
Earnings forecast
--
-$0.20
Profitability
DHT.U.TO
Sector
Profitability FY 2024
--
$3.5M
Return on invested capital
0.18%
-31.66%
Return on assets
0.16%
-27.84%
Return on equity
0.27%
-37.15%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Mar
2
Estimated Next Earnings Date
Feb
4
Balance Sheet
DHT.U.TO
Sector
Total cash
$55.7M
$26.8M
Short term investments
--
$26M
Total assets
$984.9M
$79.7M
Long term debt
$306.9M
$3.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Are the Best AI Power Stocks?
As the construction of AI infrastructure accelerates, the gap between…
Is IONQ The Best Quantum Stock to Buy?
Riding a wave of investor enthusiasm for the technology, quantum…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 60x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
73
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 39x
Alerts
Buy
80
FEIM alert for Dec 15
Frequency Electronics, Inc. [FEIM] is down 3.51% over the past day.
Buy
57
MOD alert for Dec 15
Modine Manufacturing Co. [MOD] is up 1.79% over the past day.
Sell
42
OKLO alert for Dec 15
Oklo, Inc. [OKLO] is down 5.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
